Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0016020 | membrane | 2 | 7 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 7 |
Related structures:
AlphaFold database: A4HNE0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 50 | 52 | PF00675 | 0.390 |
CLV_PCSK_KEX2_1 | 50 | 52 | PF00082 | 0.390 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.406 |
DOC_MAPK_MEF2A_6 | 75 | 82 | PF00069 | 0.349 |
DOC_MAPK_NFAT4_5 | 75 | 83 | PF00069 | 0.284 |
DOC_PP2B_PxIxI_1 | 59 | 65 | PF00149 | 0.466 |
LIG_14-3-3_CanoR_1 | 108 | 114 | PF00244 | 0.575 |
LIG_FHA_1 | 104 | 110 | PF00498 | 0.308 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.373 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.386 |
LIG_FHA_2 | 124 | 130 | PF00498 | 0.531 |
LIG_LIR_Nem_3 | 57 | 62 | PF02991 | 0.621 |
LIG_LYPXL_yS_3 | 59 | 62 | PF13949 | 0.586 |
LIG_PDZ_Class_2 | 143 | 148 | PF00595 | 0.353 |
LIG_PTB_Apo_2 | 3 | 10 | PF02174 | 0.444 |
LIG_PTB_Phospho_1 | 3 | 9 | PF10480 | 0.445 |
LIG_SH2_NCK_1 | 128 | 132 | PF00017 | 0.289 |
LIG_SH2_STAP1 | 128 | 132 | PF00017 | 0.289 |
LIG_SH2_STAT3 | 92 | 95 | PF00017 | 0.346 |
LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.554 |
LIG_SH2_STAT5 | 7 | 10 | PF00017 | 0.460 |
LIG_SUMO_SIM_anti_2 | 76 | 81 | PF11976 | 0.335 |
LIG_SUMO_SIM_par_1 | 76 | 81 | PF11976 | 0.449 |
LIG_TYR_ITSM | 55 | 62 | PF00017 | 0.598 |
MOD_CK1_1 | 65 | 71 | PF00069 | 0.335 |
MOD_CK2_1 | 123 | 129 | PF00069 | 0.531 |
MOD_GlcNHglycan | 18 | 21 | PF01048 | 0.389 |
MOD_GlcNHglycan | 64 | 67 | PF01048 | 0.376 |
MOD_GlcNHglycan | 95 | 98 | PF01048 | 0.335 |
MOD_GSK3_1 | 65 | 72 | PF00069 | 0.341 |
MOD_NEK2_1 | 16 | 21 | PF00069 | 0.439 |
MOD_NEK2_1 | 69 | 74 | PF00069 | 0.347 |
MOD_NEK2_2 | 87 | 92 | PF00069 | 0.350 |
MOD_Plk_4 | 78 | 84 | PF00069 | 0.368 |
MOD_Plk_4 | 87 | 93 | PF00069 | 0.271 |
TRG_ENDOCYTIC_2 | 59 | 62 | PF00928 | 0.602 |
TRG_ER_diArg_1 | 49 | 51 | PF00400 | 0.591 |
TRG_ER_diLys_1 | 144 | 148 | PF00400 | 0.378 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I454 | Leptomonas seymouri | 59% | 100% |
A0A0S4J9A3 | Bodo saltans | 36% | 97% |
A0A1X0P5Z3 | Trypanosomatidae | 39% | 98% |
A0A3S7XA03 | Leishmania donovani | 87% | 100% |
A0A422P158 | Trypanosoma rangeli | 42% | 100% |
A4IC13 | Leishmania infantum | 87% | 100% |
C9ZYI9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 97% |
E9B704 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
Q9N6L8 | Leishmania major | 88% | 100% |